Some prostate-cancer doctors are using a genomics test to figure out which patients need surgery and which ones can follow ‘active surveillance.
Advertisement
Post Tags:prostate cancer
Advertisement
Related Posts
This was an unexpected finding because mature TLS are typically rare in poorly immunogenic HPV-negative HNSCC.
Tumor mutations were even detected in early-stage disease.
The findings reaffirm concurrent chemoradiotherapy as a cornerstone of treatment.
Patient-derived cells have the potential to enhance drug screening tools and improve patient outcomes.
Researchers identified the pathologic and clinical characteristics of patients who experience disease relapse.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.